29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Extracellular α‐synuclein enters dopaminergic cells by modulating flotillin‐1–assisted dopamine transporter endocytosis

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The neuropathological hallmarks of Parkinson's disease (PD) include the appearance of α-synuclein (α-SYN)-positive Lewy bodies (LBs) and the loss of catecholaminergic neurons. Thus, a potential mechanism promoting the uptake of extracellular α-SYN may exist in susceptible neurons. Of the various differentially expressed proteins, we are interested in flotillin (FLOT)-1 because this protein is highly expressed in the brainstem catecholaminergic neurons and is strikingly up-regulated in PD brains. In this study, we found that extracellular monomeric and fibrillar α-SYN can potentiate FLOT1-dopamine transporter (DAT) binding and pre-endocytic clustering of DAT on the cell surface, thereby facilitating DAT endocytosis and down-regulating its transporter activity. Moreover, we demonstrated that α-SYN itself exploited the DAT endocytic process to enter dopaminergic neuron-like cells, and both FLOT1 and DAT were found to be the components of LBs. Altogether, these findings revealed a novel role of extracellular α-SYN on cellular trafficking of DAT and may provide a rationale for the cell type-specific, functional, and pathologic alterations in PD.-Kobayashi, J., Hasegawa, T., Sugeno, N., Yoshida, S., Akiyama, T., Fujimori, K., Hatakeyama, H., Miki, Y., Tomiyama, A., Kawata, Y., Fukuda, M., Kawahata, I., Yamakuni, T., Ezura, M., Kikuchi, A., Baba, T., Takeda, A., Kanzaki, M., Wakabayashi, K., Okano, H., Aoki, M. Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: not found
          • Article: not found

          Plasma membrane monoamine transporters: structure, regulation and function.

            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis

            In Parkinson’s disease (PD) there is a selective degeneration of neuromelanin-containing neurons, especially substantia nigra dopaminergic neurons. In humans, neuromelanin accumulates with age, the latter being the main risk factor for PD. The contribution of neuromelanin to PD pathogenesis remains unknown because, unlike humans, common laboratory animals lack neuromelanin. Synthesis of peripheral melanins is mediated by tyrosinase, an enzyme also present at low levels in the brain. Here we report that overexpression of human tyrosinase in rat substantia nigra results in age-dependent production of human-like neuromelanin within nigral dopaminergic neurons, up to levels reached in elderly humans. In these animals, intracellular neuromelanin accumulation above a specific threshold is associated to an age-dependent PD phenotype, including hypokinesia, Lewy body-like formation and nigrostriatal neurodegeneration. Enhancing lysosomal proteostasis reduces intracellular neuromelanin and prevents neurodegeneration in tyrosinase-overexpressing animals. Our results suggest that intracellular neuromelanin levels may set the threshold for the initiation of PD.
              • Record: found
              • Abstract: found
              • Article: not found

              Cell-to-cell transmission of non-prion protein aggregates.

              Neurodegenerative disorders such as Alzheimer disease, Parkinson disease, frontotemporal dementia, Huntington disease and Creutzfeldt-Jakob disease (CJD) are characterized by progressive accumulation of protein aggregates in selected brain regions. Protein misfolding and templated assembly into aggregates might result from an imbalance between protein synthesis, aggregation and clearance. Although protein misfolding and aggregation occur in most neurodegenerative disorders, the concept of spreading and infectivity of aggregates in the CNS has, until now, been confined to prion diseases such as CJD and bovine spongiform encephalopathy. Emerging evidence, however, suggests that prion-like spreading, involving secreted proteins such as amyloid-β and cytosolic proteins such as tau, huntingtin and α-synuclein, can occur in other neurodegenerative disorders. The underlying molecular mechanisms and the therapeutic implications of the new data are discussed in this article.

                Author and article information

                Journal
                The FASEB Journal
                FASEB j.
                Wiley
                0892-6638
                1530-6860
                June 14 2019
                September 2019
                June 18 2019
                September 2019
                : 33
                : 9
                : 10240-10256
                Affiliations
                [1 ]Division of NeurologyDepartment of Neuroscience and Sensory OrgansTohoku University Graduate School of Medicine Sendai Japan
                [2 ]Department of NeurologyNational Hospital Organization Yonezawa Hospital Yonezawa Japan
                [3 ]Department of PhysiologyKeio University School of Medicine Tokyo Japan
                [4 ]Frontier Research Institute for Interdisciplinary SciencesTohoku University Sendai Japan
                [5 ]Department of Biomedical EngineeringGraduate School of Biomedical EngineeringTohoku University Sendai Japan
                [6 ]Department of Chemistry and BiotechnologyGraduate School of EngineeringTottori University Tottori Japan
                [7 ]Department of NeuropathologyInstitute of Brain ScienceHirosaki University Graduate School of Medicine Hirosaki Japan
                [8 ]Department of NeurosurgeryNational Defense Medical College Saitama Japan
                [9 ]Department of Biomedical SciencesInstitute of Regenerative Medicine and BiofunctionGraduate School of Medical ScienceTottori University Tottori Japan
                [10 ]Laboratory of Membrane Trafficking MechanismsDepartment of Integrative Life SciencesGraduate School of Life SciencesTohoku University Sendai Japan
                [11 ]Department of PharmacotherapyGraduate School of Pharmaceutical SciencesTohoku University Sendai Japan
                [12 ]Department of NeurologyNational Hospital Organization SendaiNishitaga Hospital Sendai Japan
                Article
                10.1096/fj.201802051R
                31211923
                26e4e935-3ade-4856-8743-5c1e88fbce0a
                © 2019

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article

                Related Documents Log